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Background: As America’s third highest opioid prescribers, orthopedic surgeons have contributed to the
opioid abuse crisis. This study evaluated opioid use after primary total joint replacement. We hypothesized that patients who underwent total hip arthroplasty (THA) use fewer opioids than patients who
underwent total knee arthroplasty (TKA) and that both groups use fewer opioids than prescribed.
Methods: A prospective study of 110 patients undergoing primary THA or TKA by surgeons at an academic center during 2018 was performed. All were prescribed oxycodone 5 mg, 84 tablets, without
reﬁlls. Demographics, medical history, and operative details were collected. Pain medication consumption and patient-reported outcomes were collected at 2 and 6 weeks postoperatively. Analysis of variance
was performed on patient and surgical variables.
Results: Sixty-one patients scheduled for THA and 49 for TKA were included. THA patients consumed
signiﬁcantly fewer opioids than TKA patients at 2 weeks (28.1 tablets vs 48.4, P ¼ .0003) and 6 weeks
(33.1 vs 59.3, P ¼ .0004). Linear regression showed opioid use decreased with age at both time points
(P ¼ .0002). A preoperative mental health disorder was associated with higher usage at 2 weeks (58.3 vs
31.4, P < .0001) and 6 weeks (64.7 vs 39.2, P ¼ .006). Higher consumption at 2 weeks was correlated with
worse outcome scores at all time points.
Conclusions: TKA patients required more pain medication than THA patients, and both groups received
more opioids than necessary. In addition, younger patients and those with a preexisting mental health
disorder required more pain medication. These data provide guidance on prescribing pain medication to
help limit excess opioid distribution.
© 2020 The Authors. Published by Elsevier Inc. on behalf of The American Association of Hip and Knee
Surgeons. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Introduction
Total hip and knee arthroplasties are common surgeries in orthopedics with more than 300,000 hip replacements and 600,000
knee replacements performed each year in the United States [1].
Proper postoperative pain control leads to improved function,
outcome measures, and patient satisfaction with lower hospital
costs [2-8]. Inadequate pain control after total joint replacement
has been associated with poor results including increased healthcare costs, development of chronic pain, and worse functional
outcomes [9,10].

* Corresponding author. PO Box 9196, 64 Medical Center Drive, Morgantown, WV
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In the United States, opioids have been a cornerstone of pain
control, but they come with signiﬁcant side effects and risks. Recent
studies have shown that nearly all patients receive more pain
medication than they require after elective surgery [11-13] placing
excess opioid medication in circulation in households and communities, thereby increasing the potential for abuse and diversion.
Consequently, opioid prescribing guidelines have become an
increasingly important topic in orthopedic research. It seems
logical that the amount of pain medication required on average
depends on the type of surgery as well as both patient and surgical
characteristics. The goal of this study was to quantify the average
amount of pain medication consumed after discharge after total hip
arthroplasty (THA) and total knee arthroplasty (TKA), to compare
usage between postoperative THA and TKA, and to identify relationships between patient characteristics, postoperative outcome
measures, and actual opioid consumption. We hypothesized that

https://doi.org/10.1016/j.artd.2020.12.021
2352-3441/© 2020 The Authors. Published by Elsevier Inc. on behalf of The American Association of Hip and Knee Surgeons. This is an open access article under the CC BYNC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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total hip replacement patients would consume fewer tablets than
total knee replacement patients and that, overall, we prescribe
more tablets than necessary for most patients.
Material and methods

Table 1
Demographics of patients in the study.

Age
Gender

After obtaining institutional review board approval, patients
scheduled for THA or TKA at an academic hospital consented for
this study. Inclusion criteria included patient age of 18 years or
older scheduled for primary THA or TKA from one of 5 fellowshiptrained surgeons during the year 2018. Exclusion criteria included
prior replacement to the operative joint or patients under a pain
contract with a chronic pain management physician. Preoperative
surveys were conducted to collect comorbidities, medication use,
education level, insurance status, Hip disability and Osteoarthritis
Outcome Score (HOOS), Knee disability and Osteoarthritis Outcome
Score (KOOS), and Global Physical and Mental Score. HOOS and
KOOS are patient-reported numeric surveys with sections that
assess function, pain, and its impact on quality of life and activities
of daily living. The Global Physical and Mental Health scores are
sections of the Patient-Reported Outcomes Measurement and Information System, also patient-reported scores that assess overall
physical and mental health. Intraoperative records were reviewed
to record blood loss, tourniquet time, approach used for THA, and
type of TKA implant (cruciate retaining or posterior stabilized). In
addition to standard postoperative rehabilitation protocols, all patients were given a single prescription for oxycodone 5 mg totaling
84 tablets, a 1-week supply if 2 tablets were taken every 4 hours.
Our practice has been not to provide reﬁlls, shifting the burden of
monitoring opioid consumption to the patient. We chose 84 tablets
based on our anecdotal experience and the fact that most of our
patients live hours away. If needed, the only way to provide reﬁlls
was to provide patients with a paper prescription (State laws prevented e-prescribing or phoned-in opioid prescribing at the time
this study was conducted.). All patients received a 30 day prescription for either celecoxib or meloxicam. Patients were
permitted to supplement with acetaminophen as needed. At the 2and 6-week postoperative follow-up visits, patients were surveyed
for HOOS, KOOS, and Global Mental and Physical Scores and asked
to provide the number of tablets remaining from their oxycodone
prescription based on their own record keeping.
Continuous variables were reported using mean and standard
deviation and analyzed using regression analysis. Pill consumption
was compared between groups using independent Student t-tests
or one-way analysis of variance. One-way analysis of variance was
used to evaluate for signiﬁcant differences in opioid consumption
based on demographic and surgical characteristics. Statistical
analysis was conducted using the program JMP 14.1 (SAS Institute
Inc., Cary, NC). A P value of 0.05 or less was considered statistically
signiﬁcant.
Results
Sixty-one patients scheduled for THA and 49 for TKA participated in the study. Overall mean age was 64.8 ± 10.7 years (range,
35.5-84.0). Sixty (54.5%) of the 110 patients were female. The demographic breakdown of each operative group can be found in
Table 1. Eight patients (7.3%) did not ﬁll their opioid prescription, 5
in the THA group, and 3 in the TKA group. One of these 8 patients
was on opioids preoperatively. At the 2-week follow-up, THA patients had consumed 28.1 tablets while TKA patients consumed
48.4 tablets, a statistically signiﬁcant difference (P ¼ .0003). By
6 weeks, THA patients consumed a mean of 33.1 tablets, signiﬁcantly fewer than the 59.3 tablets TKA patients consumed (P ¼
.0004). These differences are summarized in Table 2. At 2 weeks,
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Insurance

Average
Range
Male
Female
Medicaid
Medicare
Private

THA

TKA

Total

63.3
35.5-83.6
32
29
6
27
28

66.8
42.2-84.0
31
18
4
27
18

64.8
35.5-84.0
63
47
10
54
46

THA patients had a pain level of 2.2 on a 0-10 scale, while TKA
patients had a pain level of 3.6 (P ¼ .001). At 6 weeks, THA patients
had pain level of 1.2, while TKA patients had pain scores of 2.7 (P <
.0001). Presence of preoperative opioid, NSAID, benzodiazepine, or
anticonvulsant medications had no correlation with postoperative
opioid consumption amounts. However, NSAID use in the ﬁrst
6 weeks after surgery did correlate with higher consumption of
opioid during that time. Insurance status, education level, surgeon,
approach for THA (P values of 0.44 at 2 weeks and 0.801 at 6
weeks), tourniquet time, and type of TKA implant (P values of 0.404
at 2 weeks and 0.412 at 6 weeks) had no correlation with opioid
consumption (Table 3).
Preoperative psychiatric diagnosis such as anxiety or depression
was signiﬁcantly associated with increased opioid consumption at
all time points. At 2 weeks, patients with a psychiatric history had
consumed 58.3 pills vs 31.4 pills (P < .0001). At 6 weeks, the difference was 64.7 vs 39.2 pills consumed (P ¼ .006). In all patients,
linear regression analysis showed the use of postoperative opioids
decreased signiﬁcantly with increasing age at 2 (Figure 1) and
6 weeks (P ¼ .002 at both time points) (Figure 2).
Higher consumption in the ﬁrst 2 weeks postoperatively was
associated with worse HOOS Quality of Life (P ¼ .044) and Global
Physical Score (P ¼ .0003) at 2 weeks and worse KOOS pain (P ¼
.041), KOOS Activities of Daily Living (ADL) (P ¼ .012), Global
Physical Score (P ¼ .001), and Global Mental Score (P ¼ .022) at
6 weeks. Higher consumption at 6 weeks predicted worse HOOS
ADL scores at 6 weeks (P ¼ .045).
Discussion
The opioid epidemic has forced a closer look at prescribing
habits so as not to contribute to the already escalating problem of
addiction and diversion. Greater regulation of opioid prescribing
and the logistical burden of getting a paper prescription reﬁll into
the hands of patients who live hours away saw a change in the way
we prescribe. Patients instead have been given a single prescription
of postoperative opioid and told it cannot be reﬁlled, shifting the
responsibility of tracking usage to the patient. Anecdotally, we had
observed that some patients deplete their pain pills in less than
2 weeks while others did not ﬁll the prescription at all. More
Table 2
Number of pills used and pain score on a 0-10 scale at the 2- and 6-wk postoperative
time points.

Pills used
2 wks
6 wks
Pain score
2 wks
6 wks

THA

TKA

P value

Combined

28.1
33.1

48.4
59.3

.0003
.0004

37.0
43.6

2.2
1.2

3.6
2.7

.001
<.0001

2.8
1.9

Displayed for THA and TKA patients (with P value calculated using a Student t-test)
along with average for all patients combined.
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Table 3
Breakdown of pill usage.

Hip approach
Knee implant
Insurance type

Gender
Education level

Age

Variable

Number
of patients

Pills used
at 2 wks

Pills used
at 6 wks

Direct anterior
Posterior
CR knee
PS knee
Medicaid
Medicare
Private
Female
Male
College experience
High school graduate
Less than high school
70þ
60-69
50-59
<50

23
38
18
30
10
54
46
60
50
41
26
5
41
33
28
8

28.1
28.1
48.4
48.1
36.3
37.0
37.0
37.0
37.0
37.0
37.4
59.0
37.0
35.5
37.0
37.6

33.1
31.9
59.3
59.3
43.0
43.1
43.6
43.1
43.6
43.6
45.1
73.2
43.1
42.9
43.6
38.7

Figure 2. Bivariate ﬁt of pills remaining by age at 6 wk.

CR, cruciate retaining; PS, posterior stabilized.

commonly, we had observed that THA patients complained less of
pain than TKA patients. The goal of this study was to identify if
patients receiving a THA vs a TKA required different amounts of
opioids postoperatively and to identify potential risk factors for
higher opioid needs in the period following total joint replacement.
Our hope was to be able to signiﬁcantly reduce the amount of
postoperative opioids issued to our total joint replacement patients, and to better understand the characteristics that contribute
to higher pain levels and pain medication consumption in some
patients than others.
We saw a signiﬁcant difference between the 2 surgeries, with
THA patients requiring 33.1 pills vs the 59.3 required by TKA patients in the ﬁrst 2 weeks postoperatively. Numerous retrospective
studies have shown similar results, with TKA patients being given
more and using more pain medication in the postoperative period,
as well as being more likely to develop chronic opioid use habits
after surgery [14-18]. To our knowledge, this study is the ﬁrst to
directly compare the 2 procedures prospectively with a standardized opioid prescription protocol. The reason behind the difference
in pain medication consumption is likely rooted in the painful
rehabilitation that occurs after TKA, causing a need for more pain
medication in the acute period after surgery.
Studies have identiﬁed numerous risk factors for increased
opioid use postoperatively including tobacco and alcohol abuse,

Figure 1. Bivariate ﬁt of pills remaining by age at 2 wk.

chronic pain, anxiety, depression, and benzodiazepine use [12,1719]. While older age is often cited as a risk factor for chronic
prescription opioid use in general, several studies have shown
that young age in the acute postoperative period is a risk factor
for increased opioid requirement after orthopedic surgeries [2022]. Our study mirrored these results, with opioid use
decreasing with increased age at all time points. The reasons are
likely multifactorial. Older patients typically have lower demands
in their daily lives, causing them to perform fewer painful activities in the postoperative period, prompting less opioid use. Also,
opioid-type drugs in older patients have a lower volume of distribution than in younger patients, meaning it takes a smaller
dose of drug to reach the same plasma concentration [23,24], thus
allowing older patients to reach the same blood level of medication with fewer pills. It is well described that older patients are at
greater risk of experiencing the negative effects of opioids, and
this study supports a surgeon’s decision to prescribe fewer opioids
to the elderly [24].
Of note, the authors recognized a noticeable difference in pill
consumption between the education level “less than high school”
and other education levels. As seen in Table 1, this group’s consumption at 2 and 6 weeks was 59 and 73.2 pills, respectively, over
20 pills more than all other education groups at both time points.
These data were not statistically different, likely because of only 5
patients falling into this group, but we believe it is of note. In a
study of over 14,000 patients, Ellis et al. [25] saw a correlation
between lower education levels and opioid abuse treatment. While
we are not suggesting that patients are abusing opioids, our data
show a trend that is supported in current literature. Patients with
lower education may be at higher risk of increased opioid use, a
topic deserving of future research.
The unique outcome this study evaluated was patientreported outcomes in the setting of opioid use. The most significant ﬁnding was in the relationship between pill consumption in
the ﬁrst 2 weeks and patient-reported outcome scores at the 2and 6-week time points. After THA, higher opioid consumption in
the ﬁrst 2 weeks was associated with worse HOOS Quality of Life
scores at the 2-week time point. After TKA, higher opioid consumption at 2 weeks was signiﬁcantly correlated with lower
KOOS Pain and Activities of Daily Living scores at 6 weeks. For all
patients, higher consumption at 2 weeks was associated with
worse Global Physical Scores and Global Mental Scores at the 6week visit. These relationships illustrate a connection between
acute postoperative pain, opioid use, and early patient outcomes.
While the etiology of these relationships is unclear, surgeons
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should consider patients with greater opioid use in the ﬁrst few
weeks after surgery to be at higher risk for worse outcomes.
Overall, this study shows that the main risk factors for increased
opioid use in our population are younger age, preoperative psychiatric diagnoses, higher pain scores after surgery, and TKA.
Excluding postoperative pain scores, the remaining 3 factors are all
known before surgery. These patients could be counseled that they
are likely to experience more postoperative pain and greater opioid
consumption, and surgeons can consider additional interventions
to reduce pain and opioid use after surgery.
One limitation of this study is the short-term nature of the
outcome measures. Patient-reported outcome scores were
collected up to 6 weeks postoperatively, so we are unable to
investigate the relationship of postoperative opioid consumption
with long-term outcomes. Another limitation of the study is the
way in which opioid use was tabulated relying solely on selfreported usage. We entrusted patients to log their own usage and
did not manually count remaining tablets at their return visits. Also,
this study was performed at an academic center in a rural state with
a small population and with a greater prevalence of opioid abuse.
Therefore, our patients’ postoperative opioid usage may be biased
by knowledge of the perils of opioid use and abuse that are not
generalizable to the public at large.

Conclusions
This study showed that TKA, younger age, and psychiatric diagnoses are all risk factors for increased postoperative opioid use.
Since this study was undertaken, new state laws now permit
sending opioid prescriptions electronically, thereby allowing us to
prescribe fewer pain pills at discharge and issuing reﬁlls when the
need is legitimate. Correctly estimating the amount a patient may
require for their recovery at discharge remains advantageous as it
reduces patient anxiety and administrative burden on staff. This
study has changed our prescribing patterns as we now issue fewer
pain pills to our THA patients than to our TKA patients. Furthermore, we ask patients how many pills they feel they will need at
discharge as the vast majority are committed to minimizing their
opioid use given the stigma and national attention paid to the
opioid epidemic.
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